Back to Home

Risk Adjustment & Benchmarking

Expert articles and analysis related to risk adjustment & benchmarking.

7 articles•Last 7 Days

AI Summary — Last 7 Days

Risk adjustment and benchmarking debates sharpened this week around Medicare Advantage and managed care: MedPAC’s defense of its $76B MA overpayment estimate intensified the fight between plans, policymakers, and researchers over coding intensity, encounter-data validity, and whether MA benchmarks are paying for value or selection/coding advantages. In Medicaid, implementation of the 2025 reconciliation law is creating managed care rate-setting uncertainty and potential plan exits, raising near-term risk for states, MCOs, and provider-led VBC arrangements that depend on actuarially sound capitation, stable attribution, and predictable quality/risk corridors. Together, the week’s developments point to a more contested pricing environment in which ACOs, MA plans, Medicaid MCOs, and health systems will face tighter scrutiny of benchmarks, risk scores, and whether payment models are rewarding true population-health performance versus documentation and market leverage.

Related Articles

90ALN

MedPAC Chair Defends $76 Billion Medicare Advantage Overpayment Estimate as Insurers Push Congress to Change the Math

MedPAC Chair Defends $76 Billion Medicare Advantage Overpayment Estimate as Insurers Push Congress to Change the Math  Medical Daily

Medical DailySep 26, 2026
75ALN

Implementation of 2025 Reconciliation Law: Medicaid Managed Care Rate Setting Uncertainty & Potential Plan Exits

This policy watch examines recent and anticipated managed care rate setting challenges and the potential implications of MCO exits.

KFFSep 21, 2026
70ALN

The Inverted Circuit: Attribution, Answerability, and Accountability in Canadian Health Governance

The Inverted Circuit: Attribution, Answerability, and Accountability in Canadian Health Governance  Milbank Memorial Fund

MilbankSep 22, 2026
65ALN

Medicare Advantage: What Are We Paying For?

Medicare Advantage: What Are We Paying For?  Health Affairs

Health AffairsSep 25, 2026
55ALN

Reimagining Value-Based Deals Through Risk-Pooling Models

AJMCSep 25, 2026
35ALN

CY 2027 Medicare Physician Fee Schedule Proposed Rule Could Reduce Average Reimbursement by 2.2%

Wakely’s analysis examines how proposed CY 2027 Medicare Physician Fee Schedule changes may affect reimbursement by provider specialty and geographic locality, including conversion factor, GPCI, RVU, ...

WakelySep 22, 2026
25ALN

The Tissue Systems Pathology Test Predicts Risk of Progression to High-Grade Dysplasia or Esophageal Adenocarcinoma for Patients With Non-Dysplastic Barrett's Esophagus

AJMCSep 25, 2026